VTRS
Viatris Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Input momentum (manajer yang sebanding):
keluasan pemegang +9.5% ·
aliran saham +2.3% ·
posisi baru bersih +8.7%
— formula
Akumulasi luas — peningkatan saham di lebih banyak pemegang
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q2 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 150 | -1 | 757.45M | $12.03B | +6 | −6 |
| Q1 2026 | 153 | +6 | 683.49M | $9.23B | +9 | −4 |
| Q4 2025 | 146 | -3 | 743.40M | $9.25B | +1 | −3 |
| Q3 2025 | 22 | -3 | 488.65M | $4.84B | — | −4 |
| Q2 2025 | 23 | +2 | 455.87M | $4.07B | +3 | −1 |
| Q1 2025 | 18 | -1 | 210.93M | $1.84B | +1 | −2 |
| Q4 2024 | 19 | -3 | 200.96M | $2.50B | +1 | −4 |
| Q3 2024 | 21 | +3 | 124.36M | $1.44B | +3 | — |
| Q2 2024 | 18 | — | 121.66M | $1.29B | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (pasif) | 145.12M | — | $1.30B | 0.0% | n/c | 1 | SEC ↗ |
| 2 | The Vanguard Group ✦ (pasif) | 145.12M | — | $1.30B | 0.0% | n/c | 1 | SEC ↗ |
| 3 | The Vanguard Group ✦ (pasif) | 145.12M | — | $1.30B | 0.0% | n/c | 1 | SEC ↗ |
| 4 | The Vanguard Group ✦ (pasif) | 145.12M | — | $1.30B | 0.0% | n/c | 1 | SEC ↗ |
| 5 | The Vanguard Group ✦ (pasif) | 145.12M | — | $1.30B | 0.0% | n/c | 1 | SEC ↗ |
| 6 | The Vanguard Group ✦ (pasif) | 145.12M | — | $1.30B | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (pasif) | 82.86M | — | $739.95M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (pasif) | 82.86M | — | $739.95M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (pasif) | 82.86M | — | $739.95M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (pasif) | 82.86M | — | $739.95M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (pasif) | 82.86M | — | $739.95M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (pasif) | 82.86M | — | $739.95M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (pasif) | 82.86M | — | $739.95M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (pasif) | 82.86M | — | $739.95M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (pasif) | 82.86M | — | $739.95M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (pasif) | 82.86M | — | $739.95M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (pasif) | 82.86M | — | $739.95M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | BlackRock ✦ (pasif) | 82.86M | — | $739.95M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | BlackRock ✦ (pasif) | 82.86M | — | $739.95M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | BlackRock ✦ (pasif) | 82.86M | — | $739.95M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | BlackRock ✦ (pasif) | 82.86M | — | $739.95M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | BlackRock ✦ (pasif) | 82.86M | — | $739.95M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | BlackRock ✦ (pasif) | 82.86M | — | $739.95M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | BlackRock ✦ (pasif) | 82.86M | — | $739.95M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | T. Rowe Price ✦ | 78.77M | +5.8% | $703.44M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 26 | T. Rowe Price ✦ | 78.77M | +5.8% | $703.44M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 27 | State Street Global Advisors ✦ (pasif) | 55.29M | -10.0% | $493.72M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 28 | Geode Capital Management ✦ (pasif) | 31.23M | +0.2% | $278.33M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 29 | Geode Capital Management ✦ (pasif) | 31.23M | +0.2% | $278.33M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 30 | Norges Bank ✦ (pasif) | 11.54M | -7.5% | $103.09M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 31 | Glenview Capital ✦ | 8.25M | -2.9% | $73.65M | 2.1% | ▼ Trim | 5 | SEC ↗ |
| 32 | Millennium Management ✦ | 7.67M | +132.9% | $68.52M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 33 | Arrowstreet Capital ✦ | 7.53M | +1034.8% | $67.23M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 34 | Citadel Advisors ✦ | 7.43M | +20.8% | $66.34M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 35 | Citadel Advisors ✦ | 7.43M | +20.8% | $66.34M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 36 | Fidelity (FMR) ✦ | 6.79M | — | $60.67M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Fidelity (FMR) ✦ | 6.79M | — | $60.67M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | Fidelity (FMR) ✦ | 6.79M | — | $60.67M | 0.0% | n/c | 1 | SEC ↗ |
| 39 | D. E. Shaw & Co. ✦ | 4.67M | Baru | $41.66M | 0.0% | New | 1 | SEC ↗ |
| 40 | AQR Capital Management ✦ | 3.21M | +47.2% | $28.69M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 41 | AQR Capital Management ✦ | 3.21M | +47.2% | $28.69M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 42 | AQR Capital Management ✦ | 3.21M | +47.2% | $28.69M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 43 | AQR Capital Management ✦ | 3.21M | +47.2% | $28.69M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 44 | AQR Capital Management ✦ | 3.21M | +47.2% | $28.69M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 45 | Gotham Asset Management ✦ | 2.71M | +232.7% | $24.20M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 46 | Point72 Asset Management ✦ | 948.06K | Baru | $8.47M | 0.0% | New | 1 | SEC ↗ |
| 47 | Marshall Wace ✦ | 580.46K | +123.7% | $5.18M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 48 | Marshall Wace ✦ | 580.46K | +123.7% | $5.18M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 49 | Adage Capital Partners ✦ | 480.74K | -46.3% | $4.29M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 50 | Bridgewater Associates ✦ | 341.42K | -44.1% | $3.05M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 51 | GAMCO Investors ✦ | 294.08K | -6.4% | $2.63M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 52 | Capital World Investors ✦ | 110.68K | 0.0% | $988,355 | 0.0% | Held | 5 | SEC ↗ |
| 53 | Two Sigma Investments ✦ | 25.78K | -98.3% | $230,251 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 54 | Soros Fund Management ✦ | 12.30K | Baru | $109,866 | 0.0% | New | 1 | SEC ↗ |
| 55 | Fisher Asset Management ✦ | 10.44K | -24.5% | $93,184 | 0.0% | ▼ Trim | 5 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| D. E. Shaw & Co. | $41.66M | 0.0% |
| Point72 Asset Management | $8.47M | 0.0% |
| Soros Fund Management | $109,866 | 0.0% |
Telah keluar
| Greenlight Capital (DME… | $52.27M | adalah 2.6% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 1,011 pemegang, 984.50M saham, $12.02B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.